A comparison of the Sensititre® MYCOTB panel and the agar proportion method for the susceptibility testing of Mycobacterium tuberculosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 5, 2012, Pages 835-839

  Abuali, M M ^a   Katariwala, R ^a   LaBombardi, V J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ACCURACY; AGAR PROPORTION METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; INCUBATION TIME; INTERMETHOD COMPARISON; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SENSITITRE MYCOTB METHOD;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUBERCULOSIS;

EID: 84862867357     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1382-z     Document Type: Article

References (11)

1. World Health Organization (WHO) (2010) Global Tuberculosis Control 2010. Available online at: http: //www.who.int/tb/publications/global-report/en/. WHO. Geneva, Switzerland. Accessed 1 May 2011
2. Banerjee R, Schecter GF, Flood J, Porco TC (2008) Extensively drug-resistant tuberculosis: new strains, new challenges. Expert Rev Anti Infect Ther 6(5): 713-724
3. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E (2007) Evaluation of microscopic observation drug susceptibility assay for detection of multidrugresistant Mycobacterium tuberculosis. J Clin Microbiol 45 (4): 1093-1097
4. Ahmad S, Mokaddas E (2009) Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med 103 (12): 1777-1790
5. Bwanga F, Hoffner S, Haile M, Joloba ML (2009) Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 9: 67
6. Oberhelman RA, Soto-Castellares G, Caviedes L, Castillo ME, Kissinger P, Moore DA, Evans C, Gilman RH (2006) Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method. Pediatrics 118(1): e100-e106
7. Abebe G, Paasch F, Apers L, Rigouts L, Colebunders R (2011) Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings. J Microbiol Methods 84(2): 155-160
8. Ramirez MV, Cowart KC, Campbell PJ, Morlock GP, Sikes D, Winchell JM, Posey JE (2010) Rapid detection of multidrugresistant Mycobacterium tuberculosis by use of real-time PCR and high-resolution melt analysis. J Clin Microbiol 48 (11): 4003-4009
9. Centers for Disease Control and Prevention (CDC) (2010) Molecular Detection of Drug Resistance (MDDR). Available online at: http: //www.cdc.gov/tb/topic/Laboratory/mddr.htm.Accessed 14 July 2007
10. Inderlied CB, Nash KA (1996) Antimycobacterial agents: in vitro susceptibility testing spectra of activity, mechanism of action and resistance, and assays for activity in biologic fluids. In: Lorian B (ed) Antibiotics in laboratory medicine, 3rd edn. Williams and Wilkins, Baltimore, MD, pp 127-175
11. Aono A, Hirano K, Hamasaki S, Abe C (2002) Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test. Diag Microbiol Infect Dis 44(4): 347-352